13092-Lymphomas-Non-Hodgkins-1240

Lymphomas

A PHASE 1B, MULTI-CENTER, OPEN-LABEL STUDY OF NOVEL COMBINATIONS OF CC-122, CC-223, CC-292, AND RITUXIMAB IN DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA (CC-122-DLBCL-001)

  • Details

ClinicalTrials.gov ID: NCT02031419
Diagnosis Type: Non-Hodgkins
USOR Number: 13092

  • Address

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by practice name, trial titles, indicators and specific disease types.